Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc. (CPIX) Stock Competitors & Peer Comparison
See (CPIX) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CPIX | $3.91 | +0.26% | 57.4M | -16.00 | -$0.24 | N/A |
| TAK | $18.66 | +0.00% | 59.4B | 81.72 | $0.23 | +3.18% |
| ZTS | $127.28 | -1.16% | 55.4B | 20.93 | $6.01 | +1.62% |
| HLN | $11.11 | -1.42% | 49.9B | 24.07 | $0.46 | +1.59% |
| TEVA | $34.33 | +0.32% | 38.9B | 28.03 | $1.21 | N/A |
| VTRS | $15.98 | +0.38% | 18.4B | -5.10 | -$3.13 | +3.02% |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| RGC | $33.46 | +14.71% | 13.3B | -2699.00 | -$0.01 | N/A |
| NBIX | $130.10 | +1.14% | 12.9B | 27.49 | $4.67 | N/A |
| ELAN | $25.20 | +0.88% | 12.3B | 353.50 | $0.07 | N/A |
Stock Comparison
CPIX vs TAK Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, TAK has a market cap of 59.4B. Regarding current trading prices, CPIX is priced at $3.91, while TAK trades at $18.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas TAK's P/E ratio is 81.72. In terms of profitability, CPIX's ROE is -0.13%, compared to TAK's ROE of +0.02%. Regarding short-term risk, CPIX is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check TAK's competition here
CPIX vs ZTS Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ZTS has a market cap of 55.4B. Regarding current trading prices, CPIX is priced at $3.91, while ZTS trades at $127.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ZTS's P/E ratio is 20.93. In terms of profitability, CPIX's ROE is -0.13%, compared to ZTS's ROE of +0.58%. Regarding short-term risk, CPIX is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check ZTS's competition here
CPIX vs HLN Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, HLN has a market cap of 49.9B. Regarding current trading prices, CPIX is priced at $3.91, while HLN trades at $11.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas HLN's P/E ratio is 24.07. In terms of profitability, CPIX's ROE is -0.13%, compared to HLN's ROE of +0.15%. Regarding short-term risk, CPIX is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check HLN's competition here
CPIX vs TEVA Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, TEVA has a market cap of 38.9B. Regarding current trading prices, CPIX is priced at $3.91, while TEVA trades at $34.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas TEVA's P/E ratio is 28.03. In terms of profitability, CPIX's ROE is -0.13%, compared to TEVA's ROE of +0.20%. Regarding short-term risk, CPIX is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check TEVA's competition here
CPIX vs VTRS Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, VTRS has a market cap of 18.4B. Regarding current trading prices, CPIX is priced at $3.91, while VTRS trades at $15.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas VTRS's P/E ratio is -5.10. In terms of profitability, CPIX's ROE is -0.13%, compared to VTRS's ROE of -0.23%. Regarding short-term risk, CPIX is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check VTRS's competition here
CPIX vs ITCI Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, CPIX is priced at $3.91, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ITCI's P/E ratio is -180.64. In terms of profitability, CPIX's ROE is -0.13%, compared to ITCI's ROE of -0.04%. Regarding short-term risk, CPIX is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check ITCI's competition here
CPIX vs RGC Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, RGC has a market cap of 13.3B. Regarding current trading prices, CPIX is priced at $3.91, while RGC trades at $33.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas RGC's P/E ratio is -2699.00. In terms of profitability, CPIX's ROE is -0.13%, compared to RGC's ROE of -0.62%. Regarding short-term risk, CPIX is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check RGC's competition here
CPIX vs NBIX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, NBIX has a market cap of 12.9B. Regarding current trading prices, CPIX is priced at $3.91, while NBIX trades at $130.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas NBIX's P/E ratio is 27.49. In terms of profitability, CPIX's ROE is -0.13%, compared to NBIX's ROE of +0.17%. Regarding short-term risk, CPIX is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check NBIX's competition here
CPIX vs ELAN Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ELAN has a market cap of 12.3B. Regarding current trading prices, CPIX is priced at $3.91, while ELAN trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ELAN's P/E ratio is 353.50. In terms of profitability, CPIX's ROE is -0.13%, compared to ELAN's ROE of +0.01%. Regarding short-term risk, CPIX is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check ELAN's competition here
CPIX vs RDY Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, RDY has a market cap of 12.2B. Regarding current trading prices, CPIX is priced at $3.91, while RDY trades at $14.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas RDY's P/E ratio is 19.59. In terms of profitability, CPIX's ROE is -0.13%, compared to RDY's ROE of +0.16%. Regarding short-term risk, CPIX is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check RDY's competition here
CPIX vs CTLT Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, CPIX is priced at $3.91, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas CTLT's P/E ratio is -27.84. In terms of profitability, CPIX's ROE is -0.13%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, CPIX is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check CTLT's competition here
CPIX vs LNTH Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, LNTH has a market cap of 5B. Regarding current trading prices, CPIX is priced at $3.91, while LNTH trades at $73.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas LNTH's P/E ratio is 30.46. In terms of profitability, CPIX's ROE is -0.13%, compared to LNTH's ROE of +0.15%. Regarding short-term risk, CPIX is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check LNTH's competition here
CPIX vs AMRX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, AMRX has a market cap of 4.5B. Regarding current trading prices, CPIX is priced at $3.91, while AMRX trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas AMRX's P/E ratio is 1442.00. In terms of profitability, CPIX's ROE is -0.13%, compared to AMRX's ROE of -0.05%. Regarding short-term risk, CPIX is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check AMRX's competition here
CPIX vs INDV Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, INDV has a market cap of 4.1B. Regarding current trading prices, CPIX is priced at $3.91, while INDV trades at $34.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas INDV's P/E ratio is 33.60. In terms of profitability, CPIX's ROE is -0.13%, compared to INDV's ROE of -0.60%. Regarding short-term risk, CPIX is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check INDV's competition here
CPIX vs SUPN Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, SUPN has a market cap of 2.9B. Regarding current trading prices, CPIX is priced at $3.91, while SUPN trades at $51.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas SUPN's P/E ratio is -149.09. In terms of profitability, CPIX's ROE is -0.13%, compared to SUPN's ROE of -0.02%. Regarding short-term risk, CPIX is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check SUPN's competition here
CPIX vs HCM Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, HCM has a market cap of 2.7B. Regarding current trading prices, CPIX is priced at $3.91, while HCM trades at $15.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas HCM's P/E ratio is 5.72. In terms of profitability, CPIX's ROE is -0.13%, compared to HCM's ROE of +0.47%. Regarding short-term risk, CPIX is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check HCM's competition here
CPIX vs BHC Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, BHC has a market cap of 2.2B. Regarding current trading prices, CPIX is priced at $3.91, while BHC trades at $5.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas BHC's P/E ratio is 6.18. In terms of profitability, CPIX's ROE is -0.13%, compared to BHC's ROE of -0.20%. Regarding short-term risk, CPIX is less volatile compared to BHC. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check BHC's competition here
CPIX vs DCPH Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, CPIX is priced at $3.91, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas DCPH's P/E ratio is -11.58. In terms of profitability, CPIX's ROE is -0.13%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, CPIX is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check DCPH's competition here
CPIX vs AVDL Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, CPIX is priced at $3.91, while AVDL trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, CPIX's ROE is -0.13%, compared to AVDL's ROE of -0.00%. Regarding short-term risk, CPIX is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check AVDL's competition here
CPIX vs PAHC Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, PAHC has a market cap of 2.1B. Regarding current trading prices, CPIX is priced at $3.91, while PAHC trades at $51.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas PAHC's P/E ratio is 22.80. In terms of profitability, CPIX's ROE is -0.13%, compared to PAHC's ROE of +0.31%. Regarding short-term risk, CPIX is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check PAHC's competition here
CPIX vs PRGO Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, PRGO has a market cap of 2B. Regarding current trading prices, CPIX is priced at $3.91, while PRGO trades at $14.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas PRGO's P/E ratio is -69.33. In terms of profitability, CPIX's ROE is -0.13%, compared to PRGO's ROE of -0.01%. Regarding short-term risk, CPIX is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check PRGO's competition here
CPIX vs HROW Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, HROW has a market cap of 1.9B. Regarding current trading prices, CPIX is priced at $3.91, while HROW trades at $50.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas HROW's P/E ratio is -396.54. In terms of profitability, CPIX's ROE is -0.13%, compared to HROW's ROE of -0.09%. Regarding short-term risk, CPIX is less volatile compared to HROW. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check HROW's competition here
CPIX vs EMBCV Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, CPIX is priced at $3.91, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas EMBCV's P/E ratio is N/A. In terms of profitability, CPIX's ROE is -0.13%, compared to EMBCV's ROE of -0.28%. Regarding short-term risk, CPIX is less volatile compared to EMBCV. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check EMBCV's competition here
CPIX vs DVAX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, CPIX is priced at $3.91, while DVAX trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas DVAX's P/E ratio is -41.89. In terms of profitability, CPIX's ROE is -0.13%, compared to DVAX's ROE of -0.08%. Regarding short-term risk, CPIX is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check DVAX's competition here
CPIX vs ANIP Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ANIP has a market cap of 1.7B. Regarding current trading prices, CPIX is priced at $3.91, while ANIP trades at $78.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ANIP's P/E ratio is 46.94. In terms of profitability, CPIX's ROE is -0.13%, compared to ANIP's ROE of +0.08%. Regarding short-term risk, CPIX is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check ANIP's competition here
CPIX vs TARO Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, CPIX is priced at $3.91, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas TARO's P/E ratio is 30.05. In terms of profitability, CPIX's ROE is -0.13%, compared to TARO's ROE of +0.03%. Regarding short-term risk, CPIX is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check TARO's competition here
CPIX vs COLL Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, COLL has a market cap of 1.4B. Regarding current trading prices, CPIX is priced at $3.91, while COLL trades at $45.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas COLL's P/E ratio is 27.52. In terms of profitability, CPIX's ROE is -0.13%, compared to COLL's ROE of +0.24%. Regarding short-term risk, CPIX is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check COLL's competition here
CPIX vs ALVO Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ALVO has a market cap of 1.3B. Regarding current trading prices, CPIX is priced at $3.91, while ALVO trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ALVO's P/E ratio is 18.35. In terms of profitability, CPIX's ROE is -0.13%, compared to ALVO's ROE of -0.26%. Regarding short-term risk, CPIX is less volatile compared to ALVO. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ALVO's competition here
CPIX vs AMPH Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, AMPH has a market cap of 1.3B. Regarding current trading prices, CPIX is priced at $3.91, while AMPH trades at $28.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas AMPH's P/E ratio is 12.19. In terms of profitability, CPIX's ROE is -0.13%, compared to AMPH's ROE of +0.15%. Regarding short-term risk, CPIX is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check AMPH's competition here
CPIX vs EVO Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, EVO has a market cap of 1.2B. Regarding current trading prices, CPIX is priced at $3.91, while EVO trades at $3.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas EVO's P/E ratio is -6.36. In terms of profitability, CPIX's ROE is -0.13%, compared to EVO's ROE of -0.17%. Regarding short-term risk, CPIX is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check EVO's competition here
CPIX vs CRON Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, CRON has a market cap of 1B. Regarding current trading prices, CPIX is priced at $3.91, while CRON trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas CRON's P/E ratio is 24.00. In terms of profitability, CPIX's ROE is -0.13%, compared to CRON's ROE of +0.03%. Regarding short-term risk, CPIX is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check CRON's competition here
CPIX vs PCRX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, PCRX has a market cap of 994.2M. Regarding current trading prices, CPIX is priced at $3.91, while PCRX trades at $23.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas PCRX's P/E ratio is 49.17. In terms of profitability, CPIX's ROE is -0.13%, compared to PCRX's ROE of +0.03%. Regarding short-term risk, CPIX is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check PCRX's competition here
CPIX vs PETQ Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, CPIX is priced at $3.91, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas PETQ's P/E ratio is 83.73. In terms of profitability, CPIX's ROE is -0.13%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, CPIX is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check PETQ's competition here
CPIX vs TLRY Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, TLRY has a market cap of 764.4M. Regarding current trading prices, CPIX is priced at $3.91, while TLRY trades at $7.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas TLRY's P/E ratio is -0.32. In terms of profitability, CPIX's ROE is -0.13%, compared to TLRY's ROE of -1.14%. Regarding short-term risk, CPIX is less volatile compared to TLRY. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check TLRY's competition here
CPIX vs ESPR Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ESPR has a market cap of 659.8M. Regarding current trading prices, CPIX is priced at $3.91, while ESPR trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ESPR's P/E ratio is -6.19. In terms of profitability, CPIX's ROE is -0.13%, compared to ESPR's ROE of +0.25%. Regarding short-term risk, CPIX is more volatile compared to ESPR. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check ESPR's competition here
CPIX vs EMBC Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, EMBC has a market cap of 626M. Regarding current trading prices, CPIX is priced at $3.91, while EMBC trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas EMBC's P/E ratio is 4.48. In terms of profitability, CPIX's ROE is -0.13%, compared to EMBC's ROE of -0.21%. Regarding short-term risk, CPIX is more volatile compared to EMBC. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check EMBC's competition here
CPIX vs IRWD Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, IRWD has a market cap of 610M. Regarding current trading prices, CPIX is priced at $3.91, while IRWD trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas IRWD's P/E ratio is 20.83. In terms of profitability, CPIX's ROE is -0.13%, compared to IRWD's ROE of -0.09%. Regarding short-term risk, CPIX is less volatile compared to IRWD. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check IRWD's competition here
CPIX vs CGC Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, CGC has a market cap of 591.7M. Regarding current trading prices, CPIX is priced at $3.91, while CGC trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas CGC's P/E ratio is -0.84. In terms of profitability, CPIX's ROE is -0.13%, compared to CGC's ROE of -0.53%. Regarding short-term risk, CPIX is less volatile compared to CGC. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check CGC's competition here
CPIX vs EBS Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, EBS has a market cap of 583.7M. Regarding current trading prices, CPIX is priced at $3.91, while EBS trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas EBS's P/E ratio is 8.29. In terms of profitability, CPIX's ROE is -0.13%, compared to EBS's ROE of +0.14%. Regarding short-term risk, CPIX is less volatile compared to EBS. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check EBS's competition here
CPIX vs BDSI Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, CPIX is priced at $3.91, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas BDSI's P/E ratio is 6.82. In terms of profitability, CPIX's ROE is -0.13%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, CPIX is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check BDSI's competition here
CPIX vs KMDA Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, KMDA has a market cap of 512.2M. Regarding current trading prices, CPIX is priced at $3.91, while KMDA trades at $8.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas KMDA's P/E ratio is 25.37. In terms of profitability, CPIX's ROE is -0.13%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, CPIX is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check KMDA's competition here
CPIX vs ORGO Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ORGO has a market cap of 497.5M. Regarding current trading prices, CPIX is priced at $3.91, while ORGO trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ORGO's P/E ratio is -49.00. In terms of profitability, CPIX's ROE is -0.13%, compared to ORGO's ROE of +0.00%. Regarding short-term risk, CPIX is less volatile compared to ORGO. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ORGO's competition here
CPIX vs SIGA Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, SIGA has a market cap of 480.5M. Regarding current trading prices, CPIX is priced at $3.91, while SIGA trades at $6.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas SIGA's P/E ratio is 6.51. In terms of profitability, CPIX's ROE is -0.13%, compared to SIGA's ROE of +0.35%. Regarding short-term risk, CPIX is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check SIGA's competition here
CPIX vs AQST Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, AQST has a market cap of 394.2M. Regarding current trading prices, CPIX is priced at $3.91, while AQST trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas AQST's P/E ratio is -5.67. In terms of profitability, CPIX's ROE is -0.13%, compared to AQST's ROE of +1.40%. Regarding short-term risk, CPIX is less volatile compared to AQST. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check AQST's competition here
CPIX vs SNDL Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, SNDL has a market cap of 383.7M. Regarding current trading prices, CPIX is priced at $3.91, while SNDL trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas SNDL's P/E ratio is -5.73. In terms of profitability, CPIX's ROE is -0.13%, compared to SNDL's ROE of -0.08%. Regarding short-term risk, CPIX is less volatile compared to SNDL. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check SNDL's competition here
CPIX vs ALIM Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, CPIX is priced at $3.91, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ALIM's P/E ratio is 5.28. In terms of profitability, CPIX's ROE is -0.13%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, CPIX is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check ALIM's competition here
CPIX vs EOLS Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, EOLS has a market cap of 280.7M. Regarding current trading prices, CPIX is priced at $3.91, while EOLS trades at $4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas EOLS's P/E ratio is -4.81. In terms of profitability, CPIX's ROE is -0.13%, compared to EOLS's ROE of +4.83%. Regarding short-term risk, CPIX is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check EOLS's competition here
CPIX vs LFCR Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, LFCR has a market cap of 273.1M. Regarding current trading prices, CPIX is priced at $3.91, while LFCR trades at $7.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas LFCR's P/E ratio is -5.74. In terms of profitability, CPIX's ROE is -0.13%, compared to LFCR's ROE of -2.33%. Regarding short-term risk, CPIX is less volatile compared to LFCR. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check LFCR's competition here
CPIX vs LNDC Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, CPIX is priced at $3.91, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas LNDC's P/E ratio is -4.04. In terms of profitability, CPIX's ROE is -0.13%, compared to LNDC's ROE of -15.33%. Regarding short-term risk, CPIX is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check LNDC's competition here
CPIX vs TYHT Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, CPIX is priced at $3.91, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas TYHT's P/E ratio is -1.61. In terms of profitability, CPIX's ROE is -0.13%, compared to TYHT's ROE of -0.65%. Regarding short-term risk, CPIX is less volatile compared to TYHT. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check TYHT's competition here
CPIX vs ACB Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ACB has a market cap of 207M. Regarding current trading prices, CPIX is priced at $3.91, while ACB trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ACB's P/E ratio is -3.35. In terms of profitability, CPIX's ROE is -0.13%, compared to ACB's ROE of +0.07%. Regarding short-term risk, CPIX is less volatile compared to ACB. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ACB's competition here
CPIX vs DERM Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, DERM has a market cap of 197.1M. Regarding current trading prices, CPIX is priced at $3.91, while DERM trades at $8.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas DERM's P/E ratio is -24.43. In terms of profitability, CPIX's ROE is -0.13%, compared to DERM's ROE of -0.40%. Regarding short-term risk, CPIX is less volatile compared to DERM. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check DERM's competition here
CPIX vs BGM Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, BGM has a market cap of 193.6M. Regarding current trading prices, CPIX is priced at $3.91, while BGM trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas BGM's P/E ratio is -3.33. In terms of profitability, CPIX's ROE is -0.13%, compared to BGM's ROE of -0.01%. Regarding short-term risk, CPIX is less volatile compared to BGM. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check BGM's competition here
CPIX vs OGI Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, OGI has a market cap of 189.2M. Regarding current trading prices, CPIX is priced at $3.91, while OGI trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas OGI's P/E ratio is 12.73. In terms of profitability, CPIX's ROE is -0.13%, compared to OGI's ROE of +0.05%. Regarding short-term risk, CPIX is less volatile compared to OGI. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check OGI's competition here
CPIX vs REPH Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, CPIX is priced at $3.91, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas REPH's P/E ratio is -8.04. In terms of profitability, CPIX's ROE is -0.13%, compared to REPH's ROE of -0.22%. Regarding short-term risk, CPIX is less volatile compared to REPH. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check REPH's competition here
CPIX vs THTX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, CPIX is priced at $3.91, while THTX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas THTX's P/E ratio is -17.84. In terms of profitability, CPIX's ROE is -0.13%, compared to THTX's ROE of +0.38%. Regarding short-term risk, CPIX is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check THTX's competition here
CPIX vs SCTL Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, CPIX is priced at $3.91, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas SCTL's P/E ratio is -7.86. In terms of profitability, CPIX's ROE is -0.13%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, CPIX is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check SCTL's competition here
CPIX vs TKNO Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, TKNO has a market cap of 110.3M. Regarding current trading prices, CPIX is priced at $3.91, while TKNO trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas TKNO's P/E ratio is -6.24. In terms of profitability, CPIX's ROE is -0.13%, compared to TKNO's ROE of -0.24%. Regarding short-term risk, CPIX is less volatile compared to TKNO. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check TKNO's competition here
CPIX vs CRDL Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, CRDL has a market cap of 110.1M. Regarding current trading prices, CPIX is priced at $3.91, while CRDL trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas CRDL's P/E ratio is -3.29. In terms of profitability, CPIX's ROE is -0.13%, compared to CRDL's ROE of -2.03%. Regarding short-term risk, CPIX is less volatile compared to CRDL. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check CRDL's competition here
CPIX vs PROC Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, CPIX is priced at $3.91, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas PROC's P/E ratio is 1.53. In terms of profitability, CPIX's ROE is -0.13%, compared to PROC's ROE of -2.22%. Regarding short-term risk, CPIX is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check PROC's competition here
CPIX vs OPTN Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, CPIX is priced at $3.91, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas OPTN's P/E ratio is -4.42. In terms of profitability, CPIX's ROE is -0.13%, compared to OPTN's ROE of +0.47%. Regarding short-term risk, CPIX is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check OPTN's competition here
CPIX vs ZOM Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, CPIX is priced at $3.91, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ZOM's P/E ratio is -1.62. In terms of profitability, CPIX's ROE is -0.13%, compared to ZOM's ROE of -0.59%. Regarding short-term risk, CPIX is less volatile compared to ZOM. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ZOM's competition here
CPIX vs IXHL Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, IXHL has a market cap of 94.5M. Regarding current trading prices, CPIX is priced at $3.91, while IXHL trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas IXHL's P/E ratio is -0.37. In terms of profitability, CPIX's ROE is -0.13%, compared to IXHL's ROE of -1.99%. Regarding short-term risk, CPIX is less volatile compared to IXHL. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check IXHL's competition here
CPIX vs GRVI Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, CPIX is priced at $3.91, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas GRVI's P/E ratio is 26.05. In terms of profitability, CPIX's ROE is -0.13%, compared to GRVI's ROE of -1.20%. Regarding short-term risk, CPIX is less volatile compared to GRVI. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check GRVI's competition here
CPIX vs ALVOW Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ALVOW has a market cap of 83.9M. Regarding current trading prices, CPIX is priced at $3.91, while ALVOW trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ALVOW's P/E ratio is N/A. In terms of profitability, CPIX's ROE is -0.13%, compared to ALVOW's ROE of -0.26%. Regarding short-term risk, CPIX is less volatile compared to ALVOW. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ALVOW's competition here
CPIX vs ASRT Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ASRT has a market cap of 77.3M. Regarding current trading prices, CPIX is priced at $3.91, while ASRT trades at $12.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ASRT's P/E ratio is -2.68. In terms of profitability, CPIX's ROE is -0.13%, compared to ASRT's ROE of -0.27%. Regarding short-term risk, CPIX is less volatile compared to ASRT. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ASRT's competition here
CPIX vs ZYNE Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, CPIX is priced at $3.91, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, CPIX's ROE is -0.13%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, CPIX is less volatile compared to ZYNE. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ZYNE's competition here
CPIX vs SSIC Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, CPIX is priced at $3.91, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas SSIC's P/E ratio is 11.93. In terms of profitability, CPIX's ROE is -0.13%, compared to SSIC's ROE of -0.00%. Regarding short-term risk, CPIX is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check SSIC's competition here
CPIX vs VLNS Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, CPIX is priced at $3.91, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas VLNS's P/E ratio is -1.03. In terms of profitability, CPIX's ROE is -0.13%, compared to VLNS's ROE of N/A. Regarding short-term risk, CPIX is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check VLNS's competition here
CPIX vs DRRX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, CPIX is priced at $3.91, while DRRX trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas DRRX's P/E ratio is -4.44. In terms of profitability, CPIX's ROE is -0.13%, compared to DRRX's ROE of -0.71%. Regarding short-term risk, CPIX is more volatile compared to DRRX. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check DRRX's competition here
CPIX vs JUPW Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, CPIX is priced at $3.91, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas JUPW's P/E ratio is -2.41. In terms of profitability, CPIX's ROE is -0.13%, compared to JUPW's ROE of -0.99%. Regarding short-term risk, CPIX is less volatile compared to JUPW. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check JUPW's competition here
CPIX vs INCR Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, INCR has a market cap of 45.1M. Regarding current trading prices, CPIX is priced at $3.91, while INCR trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas INCR's P/E ratio is -1.65. In terms of profitability, CPIX's ROE is -0.13%, compared to INCR's ROE of -0.17%. Regarding short-term risk, CPIX is less volatile compared to INCR. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check INCR's competition here
CPIX vs ZYBT Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ZYBT has a market cap of 41.8M. Regarding current trading prices, CPIX is priced at $3.91, while ZYBT trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ZYBT's P/E ratio is -14.70. In terms of profitability, CPIX's ROE is -0.13%, compared to ZYBT's ROE of +0.04%. Regarding short-term risk, CPIX is less volatile compared to ZYBT. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ZYBT's competition here
CPIX vs QLI Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, CPIX is priced at $3.91, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas QLI's P/E ratio is -4.92. In terms of profitability, CPIX's ROE is -0.13%, compared to QLI's ROE of -0.16%. Regarding short-term risk, CPIX is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check QLI's competition here
CPIX vs RMTI Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, RMTI has a market cap of 36.3M. Regarding current trading prices, CPIX is priced at $3.91, while RMTI trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas RMTI's P/E ratio is -5.12. In terms of profitability, CPIX's ROE is -0.13%, compared to RMTI's ROE of -0.17%. Regarding short-term risk, CPIX is less volatile compared to RMTI. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check RMTI's competition here
CPIX vs SCYX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, SCYX has a market cap of 32.3M. Regarding current trading prices, CPIX is priced at $3.91, while SCYX trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas SCYX's P/E ratio is -1.51. In terms of profitability, CPIX's ROE is -0.13%, compared to SCYX's ROE of -0.54%. Regarding short-term risk, CPIX is less volatile compared to SCYX. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check SCYX's competition here
CPIX vs HEXO Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, CPIX is priced at $3.91, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas HEXO's P/E ratio is -0.26. In terms of profitability, CPIX's ROE is -0.13%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, CPIX is less volatile compared to HEXO. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check HEXO's competition here
CPIX vs TXMD Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, TXMD has a market cap of 26.4M. Regarding current trading prices, CPIX is priced at $3.91, while TXMD trades at $2.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas TXMD's P/E ratio is 228.00. In terms of profitability, CPIX's ROE is -0.13%, compared to TXMD's ROE of +0.01%. Regarding short-term risk, CPIX is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check TXMD's competition here
CPIX vs CYTH Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, CPIX is priced at $3.91, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas CYTH's P/E ratio is -0.80. In terms of profitability, CPIX's ROE is -0.13%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, CPIX is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check CYTH's competition here
CPIX vs TLPH Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, TLPH has a market cap of 19.3M. Regarding current trading prices, CPIX is priced at $3.91, while TLPH trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas TLPH's P/E ratio is -2.47. In terms of profitability, CPIX's ROE is -0.13%, compared to TLPH's ROE of -1.26%. Regarding short-term risk, CPIX is less volatile compared to TLPH. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check TLPH's competition here
CPIX vs EVOK Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, CPIX is priced at $3.91, while EVOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas EVOK's P/E ratio is -7.97. In terms of profitability, CPIX's ROE is -0.13%, compared to EVOK's ROE of -1.01%. Regarding short-term risk, CPIX is more volatile compared to EVOK. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check EVOK's competition here
CPIX vs AYTU Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, AYTU has a market cap of 18.4M. Regarding current trading prices, CPIX is priced at $3.91, while AYTU trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas AYTU's P/E ratio is -0.66. In terms of profitability, CPIX's ROE is -0.13%, compared to AYTU's ROE of -1.07%. Regarding short-term risk, CPIX is less volatile compared to AYTU. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check AYTU's competition here
CPIX vs APUS Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, APUS has a market cap of 15.7M. Regarding current trading prices, CPIX is priced at $3.91, while APUS trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas APUS's P/E ratio is -3.04. In terms of profitability, CPIX's ROE is -0.13%, compared to APUS's ROE of -1.40%. Regarding short-term risk, CPIX is less volatile compared to APUS. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check APUS's competition here
CPIX vs ACRX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, CPIX is priced at $3.91, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ACRX's P/E ratio is -0.31. In terms of profitability, CPIX's ROE is -0.13%, compared to ACRX's ROE of -1.26%. Regarding short-term risk, CPIX is less volatile compared to ACRX. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ACRX's competition here
CPIX vs QNTM Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, QNTM has a market cap of 13.6M. Regarding current trading prices, CPIX is priced at $3.91, while QNTM trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas QNTM's P/E ratio is -0.37. In terms of profitability, CPIX's ROE is -0.13%, compared to QNTM's ROE of -3.85%. Regarding short-term risk, CPIX is more volatile compared to QNTM. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check QNTM's competition here
CPIX vs AGRX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, CPIX is priced at $3.91, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas AGRX's P/E ratio is -0.89. In terms of profitability, CPIX's ROE is -0.13%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, CPIX is less volatile compared to AGRX. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check AGRX's competition here
CPIX vs COSM Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, COSM has a market cap of 10.3M. Regarding current trading prices, CPIX is priced at $3.91, while COSM trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas COSM's P/E ratio is -0.49. In terms of profitability, CPIX's ROE is -0.13%, compared to COSM's ROE of -0.74%. Regarding short-term risk, CPIX is less volatile compared to COSM. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check COSM's competition here
CPIX vs BFRI Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, BFRI has a market cap of 10.1M. Regarding current trading prices, CPIX is priced at $3.91, while BFRI trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas BFRI's P/E ratio is -0.58. In terms of profitability, CPIX's ROE is -0.13%, compared to BFRI's ROE of +29.95%. Regarding short-term risk, CPIX is less volatile compared to BFRI. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check BFRI's competition here
CPIX vs YCBD Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, YCBD has a market cap of 9.5M. Regarding current trading prices, CPIX is priced at $3.91, while YCBD trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas YCBD's P/E ratio is -0.83. In terms of profitability, CPIX's ROE is -0.13%, compared to YCBD's ROE of -0.41%. Regarding short-term risk, CPIX is less volatile compared to YCBD. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check YCBD's competition here
CPIX vs NLTX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, CPIX is priced at $3.91, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas NLTX's P/E ratio is -0.28. In terms of profitability, CPIX's ROE is -0.13%, compared to NLTX's ROE of -0.40%. Regarding short-term risk, CPIX is less volatile compared to NLTX. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check NLTX's competition here
CPIX vs LCI Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, CPIX is priced at $3.91, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas LCI's P/E ratio is -0.04. In terms of profitability, CPIX's ROE is -0.13%, compared to LCI's ROE of +1.66%. Regarding short-term risk, CPIX is less volatile compared to LCI. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check LCI's competition here
CPIX vs BGXX Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, BGXX has a market cap of 7.3M. Regarding current trading prices, CPIX is priced at $3.91, while BGXX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas BGXX's P/E ratio is -0.76. In terms of profitability, CPIX's ROE is -0.13%, compared to BGXX's ROE of -1.16%. Regarding short-term risk, CPIX is more volatile compared to BGXX. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check BGXX's competition here
CPIX vs ADMP Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, CPIX is priced at $3.91, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas ADMP's P/E ratio is -0.08. In terms of profitability, CPIX's ROE is -0.13%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, CPIX is less volatile compared to ADMP. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check ADMP's competition here
CPIX vs GELS Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, GELS has a market cap of 6.3M. Regarding current trading prices, CPIX is priced at $3.91, while GELS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas GELS's P/E ratio is -1.36. In terms of profitability, CPIX's ROE is -0.13%, compared to GELS's ROE of -0.43%. Regarding short-term risk, CPIX is less volatile compared to GELS. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check GELS's competition here
CPIX vs SBFM Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, SBFM has a market cap of 5.6M. Regarding current trading prices, CPIX is priced at $3.91, while SBFM trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas SBFM's P/E ratio is 0.22. In terms of profitability, CPIX's ROE is -0.13%, compared to SBFM's ROE of -0.25%. Regarding short-term risk, CPIX is more volatile compared to SBFM. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check SBFM's competition here
CPIX vs SNOA Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, SNOA has a market cap of 4.9M. Regarding current trading prices, CPIX is priced at $3.91, while SNOA trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas SNOA's P/E ratio is -1.46. In terms of profitability, CPIX's ROE is -0.13%, compared to SNOA's ROE of -0.86%. Regarding short-term risk, CPIX is more volatile compared to SNOA. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check SNOA's competition here
CPIX vs MNK Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, CPIX is priced at $3.91, while MNK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas MNK's P/E ratio is -0.44. In terms of profitability, CPIX's ROE is -0.13%, compared to MNK's ROE of +0.11%. Regarding short-term risk, CPIX is less volatile compared to MNK. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check MNK's competition here
CPIX vs FLGC Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, CPIX is priced at $3.91, while FLGC trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas FLGC's P/E ratio is -0.19. In terms of profitability, CPIX's ROE is -0.13%, compared to FLGC's ROE of -0.82%. Regarding short-term risk, CPIX is less volatile compared to FLGC. This indicates potentially lower risk in terms of short-term price fluctuations for CPIX.Check FLGC's competition here
CPIX vs GHSI Comparison February 2026
CPIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPIX stands at 57.4M. In comparison, GHSI has a market cap of 4.2M. Regarding current trading prices, CPIX is priced at $3.91, while GHSI trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPIX currently has a P/E ratio of -16.00, whereas GHSI's P/E ratio is -0.79. In terms of profitability, CPIX's ROE is -0.13%, compared to GHSI's ROE of +0.01%. Regarding short-term risk, CPIX is more volatile compared to GHSI. This indicates potentially higher risk in terms of short-term price fluctuations for CPIX.Check GHSI's competition here